Pharmaceutical CRDMO service
Contributing to the improvement of pharmaceuticals and human health by
supporting the supply and development of middle-molecular APIs and
related compounds
News
-
May 8, 2023
SynCrest Launches CRDMO Service for Peptide-based Therapeutics.
-
May 8, 2023
Website launched.
-
March 13, 2023
SynCrest established as a joint venture between Otsuka Chemical and Yokogawa Electric Corporation.
